Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
ACS Omega ; 8(12): 11310-11317, 2023 Mar 28.
Artigo em Inglês | MEDLINE | ID: mdl-37008087

RESUMO

In this study, the results and experimental data under static conditions are verified based on a calculation method. The deviation is controlled within 10%, which verifies the reliability of the experimental data. It is found that pitching has the most obvious influence on heat transfer. Through an analysis of the heat transfer coefficient on the shell side and the friction pressure drop along the path, the variation under rocking conditions is obtained.

2.
Mol Cancer Ther ; 18(1): 100-111, 2019 01.
Artigo em Inglês | MEDLINE | ID: mdl-30361332

RESUMO

Receptor tyrosine kinase MET and its ligand hepatocyte growth factor (HGF) play crucial roles in many human malignancies. Numerous drugs have been developed against kinase center of MET or HGF-mediated activation; however, the outcomes in patients are not so promising. Increasing evidence show that MET has kinase-independent effects on tumorigenesis and dissemination, which explains the low efficacy in kinase inhibition-based strategy. VHH is the recombinant variable region of Camelid heavy-chain antibody. As a nanoscale antigen-binding unit, VHH has become an appealing drug candidate in cancer therapy. In our study, we choose a novel strategy to construct an anti-MET VHH pool against the whole ecto-domain of MET. Comparing to monoclonal antibody or single VHH, the anti-MET VHH pool strongly promotes MET degradation through Clathrin-dependent endo-lysosomal pathway. Thus, the anti-MET VHH pool not only blocks kinase activity of MET, but also reduces protein level of MET. As a consequence, anti-MET VHH pool dramatically suppresses cancer cell proliferation, viability, and colony formation in vitro, and inhibits tumorigenesis and growth in mice. Taken together, VHH pool-based strategy greatly improves MET-targeted therapeutic effects on cancer.


Assuntos
Resistencia a Medicamentos Antineoplásicos/efeitos dos fármacos , Neoplasias/tratamento farmacológico , Proteínas Proto-Oncogênicas c-met/química , Anticorpos de Domínio Único/administração & dosagem , Animais , Camelidae , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Células Hep G2 , Humanos , Masculino , Camundongos , Células NIH 3T3 , Neoplasias/metabolismo , Proteólise , Proteínas Proto-Oncogênicas c-met/metabolismo , Anticorpos de Domínio Único/farmacologia , Ensaios Antitumorais Modelo de Xenoenxerto
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...